Impax Laboratories recalls

Impax Laboratories has 5 recalls on record with the FDA and USDA, the earliest in 2016 and the latest reported on 28 Dec 2016. The most frequent reason is potency & assay.

Total recalls5since 2016

Last 12 months0reported

Class I120% of total

Ongoing0latest 28 Dec 2016

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 1 20%Class II 2 40%Class III 2 40%

Why impax laboratories is recalled

Product types

By year

20165100%

All impax laboratories recalls, newest first

5 total

Reported	Class	Recall	Company	Reason	Where
28 Dec 2016Drug	CLASS I	Lamotrigine Orally Disintegrating Tablets (ODT) recalled	Impax Laboratories	Packaging Defects	Nationwide
27 Apr 2016Drug	CLASS II	Dextroamphetamine Sulfate Tablets USP, 5 mg recalled	Impax Laboratories	Potency & Assay	Nationwide
27 Apr 2016Drug	CLASS II	Dextroamphetamine Sulfate Tablets USP, 10 mg recalled	Impax Laboratories	Potency & Assay	Nationwide
20 Apr 2016Drug	CLASS III	Fenofibrate Capsules (Micronized) 200 mg recalled by Impax Laboratories	Impax Laboratories	Other	Nationwide
20 Apr 2016Drug	CLASS III	Fenofibrate Capsules (Micronized) 134 mg recalled by Impax Laboratories	Impax Laboratories	Other	Nationwide

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.